The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: Current knowledge, clinical implications and future application

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 151, Issue 2, 2010, Pages 122-129

  Lapaire, Olav ^a   Shennan, Andrew ^b   Stepan, Holger ^c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Biomarkers; PlGF; Preeclampsia; sFlt 1

Indexed keywords

ENDOGLIN; PLACENTA PROTEIN; PLACENTA PROTEIN 13; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; BLINDNESS; BRAIN EDEMA; BRAIN HEMORRHAGE; CELL DIFFERENTIATION; CELL DISRUPTION; CEREBRAL BLINDNESS; CIRCULATION; DIAGNOSTIC ACCURACY; DISSEMINATED INTRAVASCULAR CLOTTING; DOPPLER ECHOGRAPHY; EARLY DIAGNOSIS; ECLAMPSIA; ENDOTHELIUM CELL; FETUS DEATH; HELLP SYNDROME; HEMOLYSIS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; JAUNDICE; KIDNEY CORTEX NECROSIS; KIDNEY TUBULE NECROSIS; KNOWLEDGE; LARYNX EDEMA; LIVER RUPTURE; LUNG EDEMA; ONTOGENY; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; RETINA EDEMA; REVIEW; SOLUTIO PLACENTAE; TROPHOBLAST; UPREGULATION;

EID: 77955515917     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2010.04.009     Document Type: Review

References (81)

1. S. Grill, C. Rusterholz, and R. Zanetti-Dallenbach et al. Potential markers of preeclampsia - a review Reprod Biol Endocrinol 7 1 2009 70 84
2. L. Duley The global impact of pre-eclampsia and eclampsia Semin Perinatol 33 3 2009 130 137
3. C.W. Redman, and I.L. Sargent Latest advances in understanding preeclampsia Science 308 5728 2005 1592 1594
4. P. Chan, M. Brown, J.M. Simpson, and G. Davis Proteinuria in pre-eclampsia: how much matters? BJOG 112 3 2005 280 285
5. B.M. Sibai Diagnosis and management of gestational hypertension and preeclampsia Obstet Gynecol 102 1 2003 181 192
6. A.K. Wikstrom, A. Larsson, U.J. Eriksson, P. Nash, and M. Olovsson Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia Acta Obstet Gynecol Scand 87 2 2008 146 153
7. C.L. Stella, and B.M. Sibai Preeclampsia: diagnosis and management of the atypical presentation J Matern Fetal Neonatal Med 19 7 2006 381 386
8. L.K. Wagner Diagnosis and management of preeclampsia Am Fam Physician 70 12 2004 2317 2324
9. L. Weinstein Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy Am J Obstet Gynecol 142 2 1982 159 167
10. P.E. Marik Hypertensive disorders of pregnancy Postgrad Med 121 2 2009 69 76
11. E. Bujold, A.M. Morency, S. Roberge, Y. Lacasse, J.C. Forest, and Y. Giguere Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis J Obstet Gynaecol Can 31 9 2009 818 826
12. H. Alfonso Preventing preeclampsia: the evidence on nutrients Nurs Womens Health 13 5 2009 419 421
13. J.R. Barton, and B.M. Sibai Prediction and prevention of recurrent preeclampsia Obstet Gynecol 112 2 Pt 1 2008 359 372
14. J.M. Wilson, and Y.G. Jungner Principles and practice of mass screening for disease Bol Oficina Sanit Panam 65 4 1968 281 393
15. S. Verlohren, A. Galindo, and D. Schlembach et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia Am J Obstet Gynecol 202 2 2010 161.e1 161.e11
16. S. Hahn, A.K. Gupta, C. Troeger, C. Rusterholz, and W. Holzgreve Disturbances in placental immunology: ready for therapeutic interventions? Springer Semin Immunopathol 27 4 2006 477 493
17. B. Huppertz The feto-maternal interface: setting the stage for potential immune interactions Semin Immunopathol 29 2 2007 83 94
18. E. Jauniaux, L. Poston, and G.J. Burton Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution Hum Reprod Update 12 6 2006 747 755
19. T.H. Hung, J.N. Skepper, D.S. Charnock-Jones, and G.J. Burton Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia Circ Res 90 12 2002 1274 1281
20. N. Soleymanlou, I. Jurisica, and O. Nevo et al. Molecular evidence of placental hypoxia in preeclampsia J Clin Endocrinol Metab 90 7 2005 4299 4308
21. S.E. Maynard, J.Y. Min, and J. Merchan et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 5 2003 649 658
22. J.M. Roberts, R.N. Taylor, T.J. Musci, G.M. Rodgers, C.A. Hubel, and M.K. McLaughlin Preeclampsia: an endothelial cell disorder Am J Obstet Gynecol 161 5 1989 1200 1204
23. B. Huppertz Placental origins of preeclampsia: challenging the current hypothesis Hypertension 51 4 2008 970 975
24. J.M. Roberts, and C.A. Hubel The two stage model of preeclampsia: variations on the theme Placenta 30 Suppl. A 2009 S32 S37
25. Action on Pre-eclampsia Pre-eclampsia Community Guideline (Precog): evidence-based screening and detection of pre-eclampsia 2004 Action on Pre-eclampsia
26. National Institute for Clinical Excellence Antenatal care: routine care for the healthy pregnant woman 2008
27. ACOG Committee on Practice Bulletins ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002 Obstet Gynecol 99 1 2002 159 167
28. D.M. Carty, C. Delles, and A.F. Dominiczak Novel biomarkers for predicting preeclampsia Trends Cardiovasc Med 18 5 2008 186 194
29. A.M. Fayyad, and K.F. Harrington Prediction and prevention of preeclampsia and IUGR Early Hum Dev 81 11 2005 865 876
30. N.G. Than, R. Romero, R. Hillermann, V. Cozzi, G. Nie, and B. Huppertz Prediction of preeclampsia - a workshop report Placenta 29 Suppl. A 2008 S83 S85
31. B. Huppertz, and L.L. Peeters Vascular biology in implantation and placentation Angiogenesis 8 2 2005 157 167
32. R. Demir, Y. Seval, and B. Huppertz Vasculogenesis and angiogenesis in the early human placenta Acta Histochem 109 4 2007 257 265
33. G. Valdes, P. Kaufmann, J. Corthorn, R. Erices, K.B. Brosnihan, and J. Joyner-Grantham Vasodilator factors in the systemic and local adaptations to pregnancy Reprod Biol Endocrinol 7 2009 79
34. C. Lam, K.H. Lim, and S.A. Karumanchi Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia Hypertension 46 5 2005 1077 1085
35. C. Signore, J.L. Mills, and C. Qian et al. Circulating angiogenic factors and placental abruption Obstet Gynecol 108 2 2006 338 344
36. I. Chafetz, I. Kuhnreich, and M. Sammar et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction Am J Obstet Gynecol 197 1 2007 35 37
37. K. Spencer, N.J. Cowans, and K.H. Nicolaides Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia Prenat Diagn 28 1 2008 7 10
38. S. Venkatesha, M. Toporsian, and C. Lam Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 6 2006 642 649 (Pubitemid 43865232)
39. R.J. Levine, C. Lam, and C. Qian et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 10 2006 992 1005
40. A.C. Staff, K. Braekke, G.M. Johnsen, S.A. Karumanchi, and N.K. Harsem Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia Am J Obstet Gynecol 197 2 2007 176.e1 176.e6
41. R.J. Levine, S.E. Maynard, and C. Qian et al. Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 7 2004 672 683
42. A. Hertig, N. Berkane, and G. Lefevre et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia Clin Chem 50 9 2004 1702 1703
43. G.C. McKeeman, J.E. Ardill, C.M. Caldwell, A.J. Hunter, and N. McClure Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop Am J Obstet Gynecol 191 4 2004 1240 1246
44. V. Tsatsaris, F. Goffin, and C. Munaut et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences J Clin Endocrinol Metab 88 11 2003 5555 5563
45. J. Woolcock, A. Hennessy, and B. Xu et al. Soluble Flt-1 as a diagnostic marker of pre-eclampsia Aust N Z J Obstet Gynaecol 48 1 2008 64 70
46. K. Koga, Y. Osuga, and O. Yoshino et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia J Clin Endocrinol Metab 88 5 2003 2348 2351
47. T. Chaiworapongsa, R. Romero, and Y.M. Kim et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia J Matern Fetal Neonatal Med 17 1 2005 3 18
48. E. Shibata, A. Rajakumar, and R.W. Powers et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor J Clin Endocrinol Metab 90 8 2005 4895 4903
49. S.Y. Kim, H.M. Ryu, and J.H. Yang et al. Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia J Korean Med Sci 22 5 2007 873 877
50. D.S. Torry, H.S. Wang, T.H. Wang, M.R. Caudle, and R.J. Torry Preeclampsia is associated with reduced serum levels of placenta growth factor Am J Obstet Gynecol 179 6 Pt 1 1998 1539 1544
51. R.N. Taylor, J. Grimwood, R.S. Taylor, M.T. McMaster, S.J. Fisher, and R.A. North Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies Am J Obstet Gynecol 188 1 2003 177 182
52. A. Reuvekamp, F.V. Velsing-Aarts, I.E. Poulina, J.J. Capello, and A.J. Duits Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia Br J Obstet Gynaecol 106 10 1999 1019 1022
53. J.C. Livingston, R. Chin, B. Haddad, E.T. McKinney, R. Ahokas, and B.M. Sibai Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia Am J Obstet Gynecol 183 6 2000 1554 1557
54. J.C. Livingston, B. Haddad, and L.A. Gorski et al. Placenta growth factor is not an early marker for the development of severe preeclampsia Am J Obstet Gynecol 184 6 2001 1218 1220
55. M.L. Tjoa, J.M. van Vugt, M.A. Mulders, R.B. Schutgens, C.B. Oudejans, and I.J. van Wijk Plasma placenta growth factor levels in midtrimester pregnancies Obstet Gynecol 98 4 2001 600 607
56. R.J. Levine, R. Thadhani, and C. Qian et al. Urinary placental growth factor and risk of preeclampsia JAMA 293 1 2005 77 85
57. S. Sunderji, E. Gaziano, and D. Wothe et al. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study Am J Obstet Gynecol 202 1 2010 40 47
58. A. De Vivo, G. Baviera, and D. Giordano et al. PlGF and sFlt-1 as markers for predicting pre-eclampsia Acta Obstet Gynecol Scand 87 8 2008 837 842
59. A. Ohkuchi, C. Hirashima, and H. Suzuki et al. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia Hypertens Res 2010 [Epub ahead of print]
60. H. Stepan, A. Unversucht, N. Wessel, and R. Faber Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion Hypertension 49 4 2007 818 824
61. H. Masuyama, T. Segawa, and Y. Sumida et al. Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia BJOG 117 3 2010 314 320
62. J.P. Kusanovic, R. Romero, and T. Chaiworapongsa et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia J Matern Fetal Neonatal Med 22 11 2009 1021 1038
63. J.H. Lim, S.Y. Kim, S.Y. Park, J.H. Yang, M.Y. Kim, and H.M. Ryu Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors Obstet Gynecol 111 6 2008 1403 1409
64. P.F. Chien, N. Arnott, A. Gordon, P. Owen, and K.S. Khan How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview BJOG 107 2 2000 196 208
65. J.S. Cnossen, R.K. Morris, and G. ter Riet et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis CMAJ 178 6 2008 701 711
66. S. Bower, S. Bewley, and S. Campbell Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging Obstet Gynecol 82 1 1993 78 83
67. H. Stepan, A. Geipel, F. Schwarz, T. Kramer, N. Wessel, and R. Faber Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion Am J Obstet Gynecol 198 2 2008 175 176
68. F. Crispi, E. Llurba, C. Dominguez, P. Martin-Gallan, L. Cabero, and E. Gratacos Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction Ultrasound Obstet Gynecol 31 3 2008 303 309
69. J. Espinoza, R. Romero, and J.K. Nien et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor Am J Obstet Gynecol 196 4 2007 326 413
70. J.S. Cnossen, R.G. ter, and B.W. Mol et al. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal Acta Obstet Gynecol Scand 88 7 2009 758 765
71. L. Duley, S. Meher, and E. Abalos Management of pre-eclampsia BMJ 332 7539 2006 463 468
72. J.M. Roberts, and D.W. Cooper Pathogenesis and genetics of pre-eclampsia Lancet 357 9249 2001 53 56
73. L. Bellamy, J.P. Casas, A.D. Hingorani, and D.J. Williams Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis BMJ 335 7627 2007 974 977
74. S.D. McDonald, A. Malinowski, Q. Zhou, S. Yusuf, and P.J. Devereaux Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses Am Heart J 156 5 2008 918 930
75. M. Sanderson, W.M. Sappenfield, K.M. Jespersen, Q. Liu, and S.L. Baker Association between level of delivery hospital and neonatal outcomes among South Carolina Medicaid recipients Am J Obstet Gynecol 183 6 2000 1504 1511
76. M.M. Bode, T.M. O'shea, K.R. Metzguer, and A.D. Stiles Perinatal regionalization and neonatal mortality in North Carolina, 1968-1994 Am J Obstet Gynecol 184 6 2001 1302 1307
77. M. Obladen, A. Luttkus, M. Rey, B. Metze, W. Hopfenmuller, and J.W. Dudenhausen Differences in morbidity and mortality according to type of referral of very low birthweight infants J Perinat Med 22 1 1994 53 64
78. Roche Diagnostics GmbH Elecsys Flt-1 (Package Insert). 05340519001-V1 2008 Roche Diagnostics GmbH Mannheim, Germany
79. Roche Diagnostics GmbH Elecsys PlGF (Package Insert). 05340420001-V1 2008 Roche Diagnostics GmbH Mannheim, Germany
80. International Academy of Perinatal Medicine The prediction and prevention of preterm birth and its consequences: an unmet challenge to perinatal medicine, science and society J Perinat Med 38 1 2010 1
81. R. Thadhani, W.P. Mutter, and M. Wolf et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia J Clin Endocrinol Metab 89 2 2004 770 775